The Application of Nanoparticle‐Based Imaging and Phototherapy for Female Reproductive Organs Diseases
review
OA: bronze
CC0
⤵ 3 in-corpus citations
AI-generated summary
This review explores nanoparticle-based imaging and phototherapies for early diagnosis and effective treatment of various female reproductive organ diseases, addressing challenges like personalization, early cancer detection, and antibiotic resistance.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Various female reproductive disorders affect millions of women worldwide and bring many troubles to women's daily life. Let alone, gynecological cancer (such as ovarian cancer and cervical cancer) is a severe threat to most women's lives. Endometriosis, pelvic inflammatory disease, and other chronic diseases-induced pain have significantly harmed women's physical and mental health. Despite recent advances in the female reproductive field, the existing challenges are still enormous such as personalization of disease, difficulty in diagnosing early cancers, antibiotic resistance in infectious diseases, etc. To confront such challenges, nanoparticle-based imaging tools and phototherapies that offer minimally invasive detection and treatment of reproductive tract-associated pathologies are indispensable and innovative. Of late, several clinical trials have also been conducted using nanoparticles for the early detection of female reproductive tract infections and cancers, targeted drug delivery, and cellular therapeutics. However, these nanoparticle trials are still nascent due to the body's delicate and complex female reproductive system. The present review comprehensively focuses on emerging nanoparticle-based imaging and phototherapies applications, which hold enormous promise for improved early diagnosis and effective treatments of various female reproductive organ diseases.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- Clinical Management of Endometriosis 2018
- The Burden of Endometriosis on Women’s Lifespan: A Narrative Overview on Quality of Life and Psychosocial Wellbeing 2020
- Endometriosis 2014
- The spectrum of imaging appearances of müllerian duct anomalies: focus on MR imaging 2017
Cited by (3)
- Nanotechnologies for the detection and treatment of endometriosis 2023
- Highly Stable and Bright NIR‐II AIE Dots for Fluorescence Imaging‐Guided Photothermal Ablation of Endometriosis 2025
- Cell membrane camouflaged and ROS responsive nanosomes for targeted endometriosis therapy via reversing inflammatory, low-autophagy, and immunotolerant microenvironment 2024
References (100)
- Clinical Management of Endometriosis via openalex
- Endometriosis via openalex
- The Burden of Endometriosis on Women’s Lifespan: A Narrative Overview on Quality of Life and Psychosocial Wellbeing via openalex
- The spectrum of imaging appearances of müllerian duct anomalies: focus on MR imaging via openalex
- W1891354937 via openalex
- W1927980476 via openalex
- W1489914900 via openalex
- W1968022263 via openalex
- W1833947617 via openalex
- W1968975986 via openalex
- W1969731650 via openalex
- W1970412285 via openalex
- W1976650998 via openalex
- W1977871291 via openalex
- W1985661535 via openalex
- W1965003174 via openalex
- W2021713080 via openalex
- W1988837024 via openalex
- W1989834585 via openalex
- W1990395091 via openalex
- W1990956554 via openalex
- W1991962739 via openalex
- W1993933662 via openalex
- W1994471946 via openalex
- W1996767771 via openalex
- W1997410326 via openalex
- W1997419062 via openalex
- W2002078334 via openalex
- W2007654892 via openalex
- W2007664451 via openalex
- W1982815904 via openalex
- W2117883159 via openalex
- W2016504202 via openalex
- W2026762108 via openalex
- W2028204215 via openalex
- W2029606255 via openalex
- W2036713511 via openalex
- W2037075525 via openalex
- W2037958826 via openalex
- W2043134793 via openalex
- W2047101821 via openalex
- W2052182172 via openalex
- W2055541309 via openalex
- W2060916027 via openalex
- W2064614508 via openalex
- W2067848116 via openalex
- W2067860730 via openalex
- W2073809897 via openalex
- W2074245293 via openalex
- W2074672624 via openalex
- W2076797886 via openalex
- W2080376276 via openalex
- W2086786288 via openalex
- W2087634915 via openalex
- W2090442378 via openalex
- W2093460728 via openalex
- W2094640203 via openalex
- W2099521317 via openalex
- W2101770250 via openalex
- W2104484443 via openalex
- W2106399070 via openalex
- W2112254175 via openalex
- W2113591972 via openalex
- W2112579958 via openalex
- W2016097990 via openalex
- W2121842066 via openalex
- W2129031411 via openalex
- W2130921381 via openalex
- W2134121821 via openalex
- W2137251285 via openalex
- W2137614389 via openalex
- W2140833524 via openalex
- W2150375936 via openalex
- W2151665064 via openalex
- W2152678860 via openalex
- W2152692460 via openalex
- W2154443533 via openalex
- W2155935996 via openalex
- W2156599429 via openalex
- W2156794539 via openalex
- W2157645104 via openalex
- W2171827756 via openalex
- W2172192547 via openalex
- W2235723738 via openalex
- W2261545566 via openalex
- W2261575366 via openalex
- W2302235323 via openalex
- W2313323444 via openalex
- W2322133568 via openalex
- W2333009577 via openalex
- W2342399740 via openalex
- W2358568694 via openalex
- W2403241044 via openalex
- W2405923460 via openalex
- W2421919823 via openalex
- W2433500317 via openalex
- W2460821710 via openalex
- W2462622469 via openalex
- W2467946880 via openalex
- W1977873050 via openalex
Cited by (3)
- Highly Stable and Bright NIR‐II AIE Dots for Fluorescence Imaging‐Guided Photothermal Ablation of Endometriosis 2025
- Cell membrane camouflaged and ROS responsive nanosomes for targeted endometriosis therapy via reversing inflammatory, low-autophagy, and immunotolerant microenvironment 2024
- Nanotechnologies for the detection and treatment of endometriosis 2023
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-06-04T00:33:56.134770+00:00
License: CC0
· commercial use OK